Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GVAX Vaccine with Autologous Stem Cell Transplant in Multiple Myeloma
NCT00024466Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Apr 2001
- Primary completion
- Dec 2004
- Modality
- Cell Therapies, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of GVAX pancreatic cancer vaccine in multiple myeloma (MM), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Apr 2001; status: completed.
02
Drugs
GVAX pancreatic cancer vaccine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00024466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00024466.